2569 related articles for article (PubMed ID: 10518312)
1. Prognosis of hepatocellular carcinoma: the BCLC staging classification.
Llovet JM; Brú C; Bruix J
Semin Liver Dis; 1999; 19(3):329-38. PubMed ID: 10518312
[TBL] [Abstract][Full Text] [Related]
2. Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score).
Kudo M; Chung H; Osaki Y
J Gastroenterol; 2003; 38(3):207-15. PubMed ID: 12673442
[TBL] [Abstract][Full Text] [Related]
3. Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials.
Llovet JM; Bustamante J; Castells A; Vilana R; Ayuso Mdel C; Sala M; Brú C; Rodés J; Bruix J
Hepatology; 1999 Jan; 29(1):62-7. PubMed ID: 9862851
[TBL] [Abstract][Full Text] [Related]
4. Comparison of three current staging systems for hepatocellular carcinoma: Japan integrated staging score, new Barcelona Clinic Liver Cancer staging classification, and Tokyo score.
Chung H; Kudo M; Takahashi S; Hagiwara S; Sakaguchi Y; Inoue T; Minami Y; Ueshima K; Fukunaga T; Matsunaga T
J Gastroenterol Hepatol; 2008 Mar; 23(3):445-52. PubMed ID: 17683486
[TBL] [Abstract][Full Text] [Related]
5. Current strategy for staging and treatment: the BCLC update and future prospects.
Forner A; Reig ME; de Lope CR; Bruix J
Semin Liver Dis; 2010 Feb; 30(1):61-74. PubMed ID: 20175034
[TBL] [Abstract][Full Text] [Related]
6. Treatment of hepatocellular carcinoma.
Forner A; Hessheimer AJ; Isabel Real M; Bruix J
Crit Rev Oncol Hematol; 2006 Nov; 60(2):89-98. PubMed ID: 16860993
[TBL] [Abstract][Full Text] [Related]
7. The efficacy of treatment schedules according to Barcelona Clinic Liver Cancer staging for hepatocellular carcinoma - Survival analysis of 3892 patients.
Wang JH; Changchien CS; Hu TH; Lee CM; Kee KM; Lin CY; Chen CL; Chen TY; Huang YJ; Lu SN
Eur J Cancer; 2008 May; 44(7):1000-6. PubMed ID: 18337087
[TBL] [Abstract][Full Text] [Related]
8. Prospective validation of the Barcelona Clinic Liver Cancer staging system.
Cillo U; Vitale A; Grigoletto F; Farinati F; Brolese A; Zanus G; Neri D; Boccagni P; Srsen N; D'Amico F; Ciarleglio FA; Bridda A; D'Amico DF
J Hepatol; 2006 Apr; 44(4):723-31. PubMed ID: 16488051
[TBL] [Abstract][Full Text] [Related]
9. Prognostic prediction in patients with hepatocellular carcinoma.
Sala M; Forner A; Varela M; Bruix J
Semin Liver Dis; 2005; 25(2):171-80. PubMed ID: 15918146
[TBL] [Abstract][Full Text] [Related]
10. Hepatectomy for stage B and stage C hepatocellular carcinoma in the Barcelona Clinic Liver Cancer classification: results of a prospective analysis.
Torzilli G; Donadon M; Marconi M; Palmisano A; Del Fabbro D; Spinelli A; Botea F; Montorsi M
Arch Surg; 2008 Nov; 143(11):1082-90. PubMed ID: 19015467
[TBL] [Abstract][Full Text] [Related]
11. Prognosis of hepatocellular carcinoma in relation to treatment across BCLC stages.
D'Avola D; Iñarrairaegui M; Pardo F; Rotellar F; Marti P; Bilbao JI; Martinez-Cuesta A; Benito A; Alegre F; Mauleón E; Herrero JI; Quiroga J; Prieto J; Sangro B
Ann Surg Oncol; 2011 Jul; 18(7):1964-71. PubMed ID: 21267791
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the usefulness of three staging systems for hepatocellular carcinoma (CLIP, BCLC, and JIS) in Japan.
Toyoda H; Kumada T; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Yamaguchi A; Isogai M; Kaneoka Y; Washizu J
Am J Gastroenterol; 2005 Aug; 100(8):1764-71. PubMed ID: 16086713
[TBL] [Abstract][Full Text] [Related]
13. The Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinoma.
Llovet JM; Fuster J; Bruix J;
Liver Transpl; 2004 Feb; 10(2 Suppl 1):S115-20. PubMed ID: 14762851
[TBL] [Abstract][Full Text] [Related]
14. The prognosis and survival analysis according to seven staging systems of hepatocellular carcinoma following curative resection.
Choi SB; Lee JG; Kim KS; Yoon DS; Choi JS; Lee WJ; Kim BR
Hepatogastroenterology; 2008; 55(88):2140-5. PubMed ID: 19260493
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of liver transplantation in 490 patients with hepatocellular carcinoma: validation of a uniform staging after surgical treatment.
Vauthey JN; Ribero D; Abdalla EK; Jonas S; Bharat A; Schumacher G; Lerut J; Chapman WC; Hemming AW; Neuhaus P
J Am Coll Surg; 2007 May; 204(5):1016-27; discussion 1027-8. PubMed ID: 17481532
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors for survival in patients with early-intermediate hepatocellular carcinoma undergoing non-surgical therapy: comparison of Okuda, CLIP, and BCLC staging systems in a single Italian centre.
Grieco A; Pompili M; Caminiti G; Miele L; Covino M; Alfei B; Rapaccini GL; Gasbarrini G
Gut; 2005 Mar; 54(3):411-8. PubMed ID: 15710992
[TBL] [Abstract][Full Text] [Related]
17. Asian consensus workshop report: expert consensus guideline for the management of intermediate and advanced hepatocellular carcinoma in Asia.
Han KH; Kudo M; Ye SL; Choi JY; Poon RT; Seong J; Park JW; Ichida T; Chung JW; Chow P; Cheng AL
Oncology; 2011; 81 Suppl 1():158-64. PubMed ID: 22212951
[TBL] [Abstract][Full Text] [Related]
18. Current treatment strategy for hepatocellular carcinoma.
Ng KK; Poon RT
Saudi Med J; 2007 Sep; 28(9):1330-8. PubMed ID: 17768455
[TBL] [Abstract][Full Text] [Related]
19. The intermediate hepatocellular carcinoma stage: Should treatment be expanded?
Piscaglia F; Bolondi L
Dig Liver Dis; 2010 Jul; 42 Suppl 3():S258-63. PubMed ID: 20547312
[TBL] [Abstract][Full Text] [Related]
20. Surgical options for hepatocellular carcinoma: resection and transplantation.
Olthoff KM
Liver Transpl Surg; 1998 Sep; 4(5 Suppl 1):S98-104. PubMed ID: 9742501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
